Skip to main content

Table 2 Criteria developed by Cancer Control and HTA Agencies

From: International lessons in new methods for grading and integrating cost effectiveness evidence into clinical practice guidelines

Cancer control initiatives National HTA agencies
National cancer control initiative (Australia)
 Health gain-disability adjusted life years (DALYs)
 (Vertical) equity-reducing inequalities in mortality rates in vulnerable populations
 Size of health burden-disease burden in DALYs and cost to health system
 Acceptability and feasibility
NICE (England and Wales)
 Clinical effectiveness
 Feasibility and impact
 Equity and equality
 Acceptability and appropriateness
British Columbia cancer control decision-makers (Canada)
 Health gain-quality adjusted life years (QALYs)
 Resource impact-budget constraints
 Resource impact- resource constraints
 Availability/advisability of alternatives
Pharmaceutical benefits advisory committee (Australia)
 Gap in current coverage
 Effectiveness and safety
 Community need